valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

PRA GROUP INC (PRAA) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$13.50 ComplexityHigh Updated
$9.60 $37.75
bear $9.60 base $23.90 bull $37.75 margin of safety $13.50 market price* $19.39
Business condition attached to the margin of safety At least two additional consecutive quarters confirming the trend already visible in H1 2026 (positive, improving operating cash flow versus the prior-year quarter) without a further increase in total debt.
PRA Group buys portfolios of defaulted consumer debt — credit cards, personal loans and similar unsecured receivables — usually for a few cents on the dollar, and then spends years collecting on them, either directly or through the courts. The business operates in the United States and across Europe (12 countries plus the United Kingdom), with smaller operations in South America, Canada and Australia; in 2025 the U.S. supplied about half of portfolio revenue, Europe about 40%, and the remaining markets about 10%. The accounting here is unusual and worth explaining, because it drives this whole analysis. When PRA buys a pool of defaulted debt, the price paid is recorded as an investment on the balance sheet, not an expense. As cash comes in, part of it is treated as investment income (revenue) and part as return of the amount originally invested (a reduction of that balance-sheet asset). Both are real cash collected from debtors, but only the 'income' portion shows up in operating cash flow; the 'return of investment' portion is grouped with the portfolio purchases themselves. On top of that, PRA regularly re-estimates how much it expects to collect from its back book, and any favorable revision flows through reported earnings immediately as non-cash 'profit,' before the cash is actually collected. To get a true read on the cash this business can generate for owners, we started from reported operating cash flow (which correctly excludes those non-cash re-estimates) and then treated portfolio purchases the way we'd treat capital spending anywhere else: money spent just to replace debt that ran off the back book during the year is a real, recurring cost of staying in business; money spent beyond that to grow the book is discretionary investment, not charged against today's earnings. PRA bought enough to more than replace what ran off in eight of the last ten years, so this mostly reduces to a straightforward calculation; in 2020-2022 the company bought less than it collected, which we count as real cash returned to owners in those years. On this basis, owner earnings have been very volatile — about $5.75 per share in the strong year of 2021, down to losses of roughly $3.20-$3.40 per share in 2023 and 2024, narrowing to a loss of about $2.15 per share in 2025. The swing to losses lines up with a deliberate shift toward pursuing collections through the legal system rather than by phone alone: this channel costs more cash up front (court costs, legal fees) for higher expected recoveries later. That bet appears to be paying off so far — PRA's own multi-year collection forecasts have been beaten by real cash for two straight years (about $156 million ahead of forecast in 2024, $121 million ahead in 2025), and the pipeline of total expected future collections has grown by about a third over the past two years. The first half of 2026, already reported, shows continued real improvement over the same period in 2025. Because the business runs in cycles — collection results depend on the price and supply of distressed debt available to buy, funding costs, and which collection channels are being used — we used the median of the full ten-year stretch, about $1.60 per share, as the normal, through-cycle level of owner earnings, rather than anchoring on either the recent trough or the unusually strong 2020-2021 years. Three cases: Bear case: the legal-channel investment keeps costing more cash than it returns for longer than expected, and owner earnings stay near breakeven to modestly negative for the next several years, recovering only to about $0.80 per share by year ten. PRA also carries meaningful debt — roughly $3.8 billion, funding the receivables book, against under $1 billion of equity — so a business that's already cash-negative has little room for error if funding conditions tighten. We don't see evidence of a near-term liquidity problem (roughly $1.1 billion of unused borrowing capacity at year-end 2025), so this case is a prolonged rough stretch rather than a collapse. Value: roughly $9.60 per share. Base case: owner earnings recover over the next four to five years as the legal-channel investment converts to cash, consistent with the track record above, reaching the historical normal of about $1.60 per share around year five and holding there. Value: roughly $23.90 per share. Bull case: the recovery is faster and fuller, and the larger, better-invested collections pipeline supports owner earnings settling modestly above the historical norm, around $2.50 per share, reflecting continued expansion in Europe (portfolio revenue there grew 17% in 2025) on top of steady U.S. purchasing. Value: roughly $37.75 per share. A reported net loss of $305 million in 2025 was driven almost entirely by a $413 million non-cash writedown of goodwill tied to a decline in the stock price, not by the collections business itself; we've excluded that charge from owner earnings as a sunk cost from a past acquisition rather than an ongoing expense. Given the size of the gap between these cases and the debt load involved, the margin-of-safety price is set at a meaningful discount to the base-case estimate, and it depends on the recovery being confirmed rather than assumed: at least two more consecutive quarters of the kind of improvement already visible in the first half of 2026, without a further buildup in debt. Once that condition is met, the margin-of-safety price is around $13.50 per share.
Fiscal yearOwner's earningsMethodology
2025 -$2.17 ▼
Same method (see FY2016 and FY2023 records). CFO=$(85.541)M; reconciliation independently verified against the filing's own reconciliation: net income (pre-NCI) $(289.974)M + SBC $15.911M + D&A/impairment of long-lived assets $10.439M + goodwill impairment $412.611M (non-cash, DBC reporting-unit impairment tied to a sustained stock-price decline; correctly added back as sunk acquisition cost) - gain on sale of equity method investment $38.403M + amortization of debt premium $7.935M - changes in expected recoveries $176.451M (non-cash favorable re-estimate, stripped out) + deferred taxes $6.389M - net unrealized FX gain $13.084M + other $0.279M + ΔWC $(21.193)M = $(85.541)M, ties exactly to reported CFO. ΔWC so -ΔWC=$21.193M; SBC=$15.911M; PP&E capex=$4.821M; portfolio purchases=$1,203.740M vs recoveries applied to principal=$1,099.148M -> purchases exceed collections (book grew ~13% in 2025), net portfolio adjustment=$0. OE=-85.541+21.193-15.911-4.821=$(85.080)M. Diluted shares=39.173M. OE/sh=$(2.17). Note: consolidated CFO includes ~$15.2M of income attributable to noncontrolling interests (South American JV) not separately backed out; immaterial to the per-share conclusion. Source: FY2025 10-K, accession 0001185348-26-000006.
2024 -$3.38 ▼
Same method (see FY2016 and FY2023 records). CFO=$(94.594)M, after a large non-cash 'changes in expected recoveries' reversal of $(240.868)M (a favorable, non-cash re-estimate of future collections that inflated GAAP net income but is stripped out starting from CFO, per this project's OE definition). ΔWC=$21.403M so -ΔWC=$(21.403)M; SBC=$13.470M; PP&E capex=$4.045M; portfolio purchases=$1,407.067M vs recoveries applied to principal=$1,027.896M -> purchases exceed collections, net portfolio adjustment=$0. OE=-94.594-21.403-13.470-4.045=$(133.512)M. Diluted shares=39.542M. OE/sh=$(3.38). Source: FY2024 10-K, accession 0001185348-25-000006.
2023 -$3.19 ▼
Same method (see FY2016 record). CFO=$(97.535)M (negative; reconciles to net income $(66.754)M pre-NCI plus SBC $11.095M, D&A $18.615M, amortization of debt premium $9.223M, deferred tax $(35.942)M, FX $(16.552)M, other $(1.534)M, and ΔWC $13.448M -- 'changes in expected recoveries' add-back of only $29.134M this year, far smaller than 2024/2025, meaning less of the period's reported profit was a non-cash re-estimate); ΔWC=$13.448M so -ΔWC=$(13.448)M; SBC=$11.095M; PP&E capex=$2.887M; portfolio purchases=$1,160.289M vs recoveries applied to negative allowance=$917.025M -> purchases exceed collections (book growing again after the 2020-2022 pause), net portfolio adjustment=$0. OE=-97.535-13.448-11.095-2.887=$(124.965)M. Diluted shares=39.177M. OE/sh=$(3.19). Source: FY2023 10-K, accession 0001185348-24-000012.
2022 $3.20 ▼
Same method (see FY2016 and FY2020 records). CFO=$21.592M; ΔWC=$(1.712)M so -ΔWC=$1.712M; SBC=$13.047M; PP&E capex=$13.251M; portfolio purchases=$844.255M vs recoveries applied to negative allowance=$974.846M -> shortfall of $130.591M added back as harvest. OE=21.592+1.712-13.047-13.251+130.591=$127.597M. Diluted shares=39.888M. OE/sh=$3.20. Source: FY2022 10-K, accession 0001185348-23-000007.
2021 $5.75 ▼
Same method (see FY2016 and FY2020 records). CFO=$84.925M; ΔWC=$11.407M so -ΔWC=$(11.407)M; SBC=$15.940M; PP&E capex=$11.212M; portfolio purchases=$971.708M vs recoveries applied to negative allowance=$1,185.954M -> shortfall of $214.246M added back as harvest (continued light purchasing relative to collections). OE=84.925-11.407-15.940-11.212+214.246=$260.612M. Diluted shares=45.330M. OE/sh=$5.75. Source: FY2021 10-K, accession 0001185348-22-000005.
2020 $4.61 ▼
Same method (see FY2016 record); FY2020 is the first year under CECL (negative-allowance) accounting, which changed income-statement mechanics but not the cash-flow-statement items this calc relies on. CFO=$141.704M; ΔWC=$32.523M (incl. right-of-use line) so -ΔWC=$(32.523)M; SBC=$14.387M; PP&E capex=$17.230M; portfolio purchases=$903.588M vs 'recoveries applied to negative allowance' (CECL-era label for collections applied to principal)=$1,037.659M -> purchases FELL SHORT of collections by $134.071M (company pulled back purchasing amid COVID-era uncertainty while continuing to collect the back book), so maintenance purchase=actual purchases and the $134.071M shortfall is added back as a real cash harvest. OE=141.704-32.523-14.387-17.230+134.071=$211.635M. Diluted shares=45.860M. OE/sh=$4.61. Source: FY2020 10-K, accession 0001185348-21-000006.
2019 $2.11 ▼
Same method (see FY2016 record). CFO=$133.388M; ΔWC=$8.680M so -ΔWC=$(8.680)M; SBC=$10.717M; PP&E capex=$18.033M; portfolio purchases=$1,231.351M vs collections applied to principal=$842.910M -> purchases exceed collections, net portfolio adjustment=$0. OE=133.388-8.680-10.717-18.033=$95.958M. Diluted shares=45.577M. OE/sh=$2.11. Source: FY2019 10-K, accession 0001185348-20-000004.
2018 $1.09 ▼
Same method (see FY2016 record). CFO=$80.866M; ΔWC=$2.362M so -ΔWC=$(2.362)M; SBC=$8.521M; PP&E capex=$20.521M; portfolio purchases=$1,105.759M vs collections applied to principal=$733.306M -> purchases exceed collections, net portfolio adjustment=$0. OE=80.866-2.362-8.521-20.521=$49.462M. Diluted shares=45.413M. OE/sh=$1.09. Source: FY2018 10-K, accession 0001185348-19-000009.
2017 $0.35 ▼
Same method as FY2016 (see that record for the portfolio-purchase treatment). CFO=$15.475M; ΔWC=$(32.143)M so -ΔWC=+$32.143M; SBC=$8.678M; PP&E capex=$22.840M; portfolio purchases=$1,086.029M vs collections applied to principal=$717.170M -> purchases exceed collections, maintenance purchase=collections=$717.170M, net portfolio adjustment=$0 (purchases>=collections). OE=15.475+32.143-8.678-22.840=$16.100M. Diluted shares=45.823M. OE/sh=$0.35. Source: FY2017 10-K, accession 0001185348-18-000008 (figures as restated in FY2018 10-K, accession 0001185348-19-000009).
2016 $4.16 ▼
PRA Group is a debt buyer; portfolio purchases sit in investing, not operating, so OE = CFO - ΔWC - SBC - PP&E capex - maintenance portfolio purchase, where maintenance portfolio purchase = min(portfolio purchases, collections applied to principal) (replacement-only; any purchases beyond principal collected are growth investment, not deducted, and if purchases fall short of collections the shortfall is added back as a harvest). CFO=$205.903M; ΔWC(other assets/receivables/AP/taxes/accrued/other liab)=$(7.544)M so -ΔWC=+$7.544M; SBC=$6.138M; PP&E capex=$14.160M (treated in full as maintenance; immaterial vs. revenue); portfolio purchases=$890.803M vs collections applied to principal=$646.844M -> purchases exceed collections (book growing) so maintenance portfolio purchase=$646.844M, harvest add-back=$0. OE=205.903+7.544-6.138-14.160-646.844+646.844(offsetting, net effect $0 since purchases>=collections)=$193.149M. Diluted shares=46.388M. OE/sh=$4.16. Source: FY2016 10-K, accession 0001185348-17-000012 (figures as restated in FY2018 10-K, accession 0001185348-19-000009).

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (nationwide); Europe — operations in 12 countries plus the United Kingdom (roughly 40% of 2025 portfolio revenue, with the UK and other core European markets the largest contributors); smaller operations in South America (including Colombia), Canada and Australia (about 10% of 2025 portfolio revenue combined).
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis

We don't have chart analysis for this company yet.

Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.